Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TILDRAKIZUMAB-ASMN Cause Wrong technique in product usage process? 6 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Wrong technique in product usage process have been filed in association with TILDRAKIZUMAB-ASMN. This represents 0.4% of all adverse event reports for TILDRAKIZUMAB-ASMN.

6
Reports of Wrong technique in product usage process with TILDRAKIZUMAB-ASMN
0.4%
of all TILDRAKIZUMAB-ASMN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Wrong technique in product usage process From TILDRAKIZUMAB-ASMN?

Of the 6 reports.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?

Product dose omission issue (363) Drug ineffective (223) Psoriasis (86) Death (84) Product storage error (74) Self-medication (74) Off label use (66) Condition aggravated (63) Rash (54) Pruritus (52)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Wrong technique in product usage process Risk?

TILDRAKIZUMAB-ASMN vs TILIDINE TILDRAKIZUMAB-ASMN vs TIMOLOL TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST TILDRAKIZUMAB-ASMN vs TINIDAZOLE TILDRAKIZUMAB-ASMN vs TINZAPARIN

Related Pages

TILDRAKIZUMAB-ASMN Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process TILDRAKIZUMAB-ASMN Demographics